Zhaoke Ophthalmology Limited (HKG:6622)

Zhaoke Ophthalmology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	69.32	18.75	-	-	-
Revenue Growth (YoY)	269.73%	-	-	-	-
Cost of Revenue	17.53	4.5	-	-	-
Gross Profit	51.8	14.25	-	-	-
Selling, General & Admin	134.28	136.29	116.06	178.82	36.54
Research & Development	203.7	333.05	296.43	220.06	81.78
Other Operating Expenses	-1.28	-1.39	-0.15	-0.01	-1.37
Operating Expenses	336.71	467.95	412.34	398.87	116.96
Operating Income	-284.91	-453.71	-412.34	-398.87	-116.96
Interest Expense	-9.5	-7.92	-3.14	-1.95	-1.66
Interest & Investment Income	75.23	77.4	30.42	5.04	2.58
Currency Exchange Gain (Loss)	-18.31	-3.65	-29.73	13.41	-5.49
Other Non Operating Income (Expenses)	-	-	-	-1,763	-669.98
EBT Excluding Unusual Items	-237.49	-387.88	-414.8	-2,146	-791.49
Other Unusual Items	-	3.39	7.48	16.09	64.51
Pretax Income	-237.49	-384.49	-407.32	-2,130	-726.98
Income Tax Expense	-	0.55	-	-	-
Net Income	-237.49	-385.04	-407.32	-2,130	-726.98
Net Income to Common	-237.49	-385.04	-407.32	-2,130	-726.98
Shares Outstanding (Basic)	546	544	542	412	151
Shares Outstanding (Diluted)	546	544	542	412	151
Shares Change (YoY)	0.41%	0.32%	31.47%	173.12%	-5.63%
EPS (Basic)	-0.43	-0.71	-0.75	-5.16	-4.81
EPS (Diluted)	-0.43	-0.71	-0.75	-5.16	-4.81
Free Cash Flow	-	-360.13	-409.7	-310.67	-169.79
Free Cash Flow Per Share	-	-0.66	-0.76	-0.75	-1.12
Gross Margin	74.72%	75.98%	-	-	-
Operating Margin	-410.98%	-2419.76%	-	-	-
Profit Margin	-342.58%	-2053.54%	-	-	-
Free Cash Flow Margin	-	-1920.70%	-	-	-
EBITDA	-251.23	-420.03	-384.55	-377.53	-100.7
D&A For EBITDA	33.68	33.68	27.78	21.34	16.25
EBIT	-284.91	-453.71	-412.34	-398.87	-116.96

Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.